|
Quotes & Info
|
| ARRY > SEC Filings for ARRY > Form 8-K on 21-Apr-2009 | All Recent SEC Filings |
21-Apr-2009
Other Events, Financial Statements and Exhibits
On April 21, 2009, Array BioPharma Inc. issued a press release announcing that ARRY-520 demonstrates significant activity in hematological and taxane - resistant tumors. The full text of this press release is attached hereto as Exhibit 99.1.
(d) Exhibits.
99.1 Press release dated April 21, 2009 entitled "Array BioPharma's ARRY-520 Demonstrates Significant Activity in Hematological and Taxane - Resistant Tumors."
|
|